Efficacy of mycophenolate mofetil in sarcoidosis

Respiratory Medicine

Volumn 108, Issue 11, 2014, Pages 1663-1669

  Hamzeh, Nabeel ^b,c   Voelker, Allison ^a   Forssén, Anna ^b   Gottschall, E Brigitte ^a,b,c   Rose, Cecile ^a,b,c   Mroz, Peggy ^b   Maier, Lisa A ^a,b,c  

^a Food Science and Human Nutrition   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Mycophenolate mofetil; Sarcoidosis; Treatment

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL ARTICLE; DECUBITUS; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LONGITUDINAL STUDY; LOOSE FECES; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MALE; MEDICAL RECORD REVIEW; NAUSEA; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; AGED; ANALOGS AND DERIVATIVES; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECTS; DRUG SCREENING; LUNG DIFFUSION CAPACITY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; AGED; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84922560462     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.09.013     Document Type: Article

References (19)

1. Statement on sarcoidosis Am J Respir Crit Care Med 160 1999 736 755
2. S. Paramothayan, T.J. Lasserson, and E.H. Walters Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis Cochrane Database Syst Rev 3 2006 CD003536 [Online]
3. S.P. Paramothayan, and Paul W. Jones Corticosteroid therapy in pulmonary sarcoidosis: a systematic review JAMA 287 2002 1301 1307
4. N.S. Paramothayan, T.J. Lasserson, and P.W. Jones Corticosteroids for pulmonary sarcoidosis Cochrane Database Syst Rev 2005 CD001114 [Online]
5. C.R. Keenan, S. Salem, E.R. Fietz, R.C. Gualano, and A.G. Stewart Glucocorticoid-resistant asthma and novel anti-inflammatory drugs Drug Discov Today 17 2012 1031 1038
6. R.P. Baughman, H. Nunes, N.J. Sweiss, and E.E. Lower Established and experimental medical therapy of pulmonary sarcoidosis Eur Respir J 41 2013 1424 1438
7. A.C. Schutt, W.M. Bullington, and M.A. Judson Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study Respir Med 104 2010 717 723
8. R.P. Baughman, and E.E. Lower A clinical approach to the use of methotrexate for sarcoidosis Thorax 54 1999 742 746
9. D.H. Sahoo, D. Bandyopadhyay, and M. Xu Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis Eur Respir J 38 2011 1145 1150
10. R.P. Baughman, and E.E. Lower Leflunomide for chronic sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 21 2004 43 48
11. A.D. Vorselaars, W.A. Wuyts, and V.M. Vorselaars Methotrexate vs azathioprine in second-line therapy of sarcoidosis Chest 144 2013 805 812
12. A.K. Brill, S.R. Ott, and T. Geiser Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study Respiration 86 2013 376 383
13. A. Fischer, K.K. Brown, and R.M. Du Bois Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease J Rheumatol 40 2013 640 646
14. J.J. Swigris, A.L. Olson, and A. Fischer Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease Chest 130 2006 30 36
15. M.R. Miller, R. Crapo, and J. Hankinson General considerations for lung function testing Eur Respir J 26 2005 153 161
16. R.P. Baughman, M. Drent, and D.A. Culver Endpoints for clinical trials of sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 29 2012 90 98
17. R.P. Baughman, D.B. Winget, and E.E. Lower Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial Sarcoidosis Vasc Diffuse Lung Dis 17 2000 60 66
18. R.P. Baughman, and E.E. Lower Infliximab for refractory sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 18 2001 70 74
19. E.E. Lower, and R.P. Baughman Prolonged use of methotrexate for sarcoidosis Arch Intern Med 155 1995 846 851